Iovance Biotherapeutics (IOVA) Operating Income US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
Operating Income, bln rub -206.9 -261.9 -342.7 -398.9 -460.6   -467.4  
Changes by years, y/y, % +61% +27% +31% +16% +15%     +29.1%

Iovance Biotherapeutics. Operating Income, bln rub

Iovance Biotherapeutics. Operating Income, changes, %

Iovance Biotherapeutics. Operating Income, sum by quarters, bln rub

Iovance Biotherapeutics (IOVA) Operating Income US GAAP (quarter values)

2023Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
Operating Income, bln rub -110.9 -110.1 -118.4 -121.3 -117.7   -467.4
Changes by years, y/y, % +21% +10% +18% +13% +6%    
Changes by quarters, q/q, % +4% -1% +8% +2% -3%    

Iovance Biotherapeutics. Operating Income, bln rub

Iovance Biotherapeutics. Operating Income, changes, y/y, %

Iovance Biotherapeutics. Operating Income, changes, q/q, %